Etelcalcetide

Etelcalcetide es un fármaco en desarrollo de Amgen. Tiene 11 ensayos clínicos registrados, 2 en marcha; lo más avanzado, fase 3.

AMGN Amgen

Sus ensayos

Para qué	Fase	Estado
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis NCT03969329	Fase 3	Reclutando pacientes
Enfermedad renal crónica NCT03633708	Fase 3	Reclutando pacientes
Enfermedad renal crónica NCT03299244	Fase 3	Completado
A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416 NCT03283098	Fase 1	Completado
A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis NCT02833857	Fase 1	Completado
Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis NCT02102204	Fase 3	Completado
Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis NCT01785875	Fase 3	Completado
Enfermedad renal crónica NCT01896232	Fase 3	Completado
Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis NCT01785849	Fase 3	Completado
Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis NCT01788046	Fase 3	Completado
Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide NCT01932970	Fase 3	Completado

¿Cuándo se esperan resultados? Está en el calendario, para quien tiene cuenta. Crear una cuenta.

Ensayos del registro público de ClinicalTrials.gov; noticias, de los documentos que la empresa presenta ante la SEC. No son recomendaciones de inversión.